Idiopathic cardiomyopathies. A review of pathologic studies and mechanisms of pathogenesis

Insights

This review critically examines human cardiomyopathy mechanisms, highlighting challenges in classification and exploring potential autoimmune origins for this complex cardiac condition.

Area of Science:

  • Cardiology
  • Pathology
  • Immunology

Background:

  • Human cardiomyopathy presents diagnostic challenges due to an empirical and vague classification system.
  • Dilated cardiomyopathies, in particular, likely represent multiple distinct conditions under a broad umbrella term.

Purpose of the Study:

  • To critically review current knowledge on pathogenic mechanisms of human cardiomyopathy.
  • To emphasize difficulties in patient categorization for pathogenesis research.
  • To present recent findings on cardiomyopathy origins, including potential autoimmune basis and immunologic study results.

Main Methods:

  • Review of existing literature on cardiomyopathy.
  • Analysis of morphologic findings (gross, microscopic, ultrastructural).
  • Correlation of morphologic findings with clinical presentation and diagnostic modalities.

Main Results:

  • Current cardiomyopathy classification is empirical and vague, hindering research.
  • Dilated cardiomyopathies are likely heterogeneous, requiring reclassification.
  • Emerging evidence suggests a possible autoimmune basis for some cardiomyopathies.

Conclusions:

  • Revising cardiomyopathy classification is crucial for advancing research into its origins and pathogenesis.
  • Further immunologic studies are needed to elucidate the role of autoimmunity in cardiomyopathy.
  • A clearer understanding of cardiomyopathy subtypes will improve diagnosis and prognosis.

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...